236 related articles for article (PubMed ID: 35868165)
1. Antigen-specific immunotherapies in type 1 diabetes.
Zhang X; Dong Y; Liu D; Yang L; Xu J; Wang Q
J Trace Elem Med Biol; 2022 Sep; 73():127040. PubMed ID: 35868165
[TBL] [Abstract][Full Text] [Related]
2. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
Yi B; Huang G; Zhou ZG
Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
[TBL] [Abstract][Full Text] [Related]
3. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
[TBL] [Abstract][Full Text] [Related]
4. Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes.
Rogowicz-Frontczak A; Pilacinski S; Wyka K; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
Diabetes Res Clin Pract; 2018 Dec; 146():313-320. PubMed ID: 30465779
[TBL] [Abstract][Full Text] [Related]
5. Anti-Zinc Transporter Protein 8 Antibody Testing Is Not Informative in Routine Prediabetes Screening in Young Patients with Autoimmune Thyroiditis and Celiac Disease.
Larizza D; De Amici M; Klersy C; Albanesi M; Albertini R; Badulli C; Torre C; Calcaterra V
Horm Res Paediatr; 2016; 86(2):100-105. PubMed ID: 27487045
[TBL] [Abstract][Full Text] [Related]
6. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams CL; Long AE
Diabetologia; 2019 Nov; 62(11):1969-1976. PubMed ID: 31444530
[TBL] [Abstract][Full Text] [Related]
7. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
8. Immune therapy in type 1 diabetes mellitus.
Lernmark A; Larsson HE
Nat Rev Endocrinol; 2013 Feb; 9(2):92-103. PubMed ID: 23296174
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes.
Incani M; Serafini C; Satta C; Perra L; Scano F; Frongia P; Ricciardi R; Ripoli C; Soro M; Strazzera A; Zampetti S; Buzzetti R; Cavallo MG; Cossu E; Baroni MG
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27726307
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.
Niechciał E; Rogowicz-Frontczak A; Piłaciński S; Fichna M; Skowrońska B; Fichna P; Zozulińska-Ziółkiewicz D
Acta Diabetol; 2018 Mar; 55(3):287-294. PubMed ID: 29327148
[TBL] [Abstract][Full Text] [Related]
11. Update on the ZNT8 epitope and its role in the pathogenesis of type 1 diabetes.
Yang L; Zhang X; Liu Q; Wen Y; Wang Q
Minerva Endocrinol (Torino); 2023 Dec; 48(4):447-458. PubMed ID: 38099391
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic basis of immunotherapies for type 1 diabetes mellitus.
Chen W; Xie A; Chan L
Transl Res; 2013 Apr; 161(4):217-29. PubMed ID: 23348026
[TBL] [Abstract][Full Text] [Related]
13. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
[TBL] [Abstract][Full Text] [Related]
14. Cell-Surface Autoantibody Targets Zinc Transporter-8 (ZnT8) for In Vivo β-Cell Imaging and Islet-Specific Therapies.
Guo Z; Kasinathan D; Merriman C; Nakayama M; Li H; Li H; Xu C; Wong GW; Yu L; Golson ML; Fu D
Diabetes; 2023 Feb; 72(2):184-195. PubMed ID: 36448936
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes.
Głowińska-Olszewska B; Michalak J; Łuczyński W; Del Pilar Larosa M; Chen S; Furmaniak J; Smith BR; Bossowski A
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):647-56. PubMed ID: 27008690
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetes pathogenesis - Prevention???
Krishna CS; Srikanta S
Indian J Endocrinol Metab; 2015 Apr; 19(Suppl 1):S58-63. PubMed ID: 25941654
[TBL] [Abstract][Full Text] [Related]
18. Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study.
Siddiqui K; Nawaz SS; Alfadda AA; Mujammami M
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238221
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to Zinc Transporter 8 and
Fakhfakh R; Kmiha S; Tahri S; Feki S; Zouidi F; Abida O; Hachicha M; Kammoun T; Masmoudi H
J Diabetes Res; 2022; 2022():2539871. PubMed ID: 35656360
[TBL] [Abstract][Full Text] [Related]
20. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
